Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| KPTI | CLUSTER | neutral | 3/10 | Six KPTI insiders, including the CEO and other C-suite executives, sold a total of $35K in shares on May 14, 2026, the s | May 26, 2026 |
| KPTI | CLUSTER | neutral | 2/10 | Six KPTI insiders, including CEO Richard Paulson, sold shares on May 14 (the same day as Q1 earnings), totaling $35,000 | May 26, 2026 |
| TWST | CLUSTER | neutral | 3/10 | Six TWST insiders, including the CEO, CFO, and COO, collectively sold 16,796 shares for ~$807K on May 21, 2026, all at $ | May 26, 2026 |
| BTAI | CLUSTER | bearish | 5/10 | Three top insiders at BioXcel Therapeutics (CEO, CFO, and another executive) collectively sold $35.6K in open-market sha | May 22, 2026 |
| MRNA | CLUSTER | neutral | 2/10 | Two Moderna insiders sold a total of $3.02M in open-market sales over a 7-day window. Director Noubar Afeyan exercised a | May 22, 2026 |
| MDGL | CLUSTER | neutral | 3/10 | Two Madrigal insiders (Director Levy and CMO Soergel) sold a combined $456K in open-market transactions, representing ap | May 22, 2026 |
| ABEO | CLUSTER | neutral | 2/10 | Two directors at Abeona Therapeutics sold a total of $180K in open-market transactions within a week of the company's Q1 | May 22, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | Three UTHR insiders including the CEO, CFO, and EVP & General Counsel executed a series of option exercises and small op | May 22, 2026 |
| EXEL | CLUSTER | neutral | 3/10 | Three senior executives at Exelixis (CFO, EVP Commercial, SVP/GC) collectively sold $3.68M in open-market shares within | May 22, 2026 |
| ORKA | CLUSTER | neutral | 3/10 | Director Carl Dambkowski and SVP Arjun Agarwal executed derivative exercises and open-market sales, with total open-mark | May 22, 2026 |
| GEVO | CLUSTER | neutral | 2/10 | Two GEVO insiders sold $103K total in a tight 8-day window: President & COO Michael sold $88K (29.8K shares at $2.96) an | May 22, 2026 |
| GEVO | CLUSTER | neutral | 2/10 | Two GEVO insiders (President & COO and Chief Cust Mkt & Brnd Officer) executed open-market sales totaling $103K between | May 22, 2026 |
| ARDX | CLUSTER | neutral | 2/10 | Seven ARDX insiders, including CEO and CFO, sold a combined $176K in shares on May 21, 2026, all at the same price of $6 | May 22, 2026 |
| ARDX | CLUSTER | neutral | 3/10 | Four C-suite insiders at Ardelyx sold $141K in open-market sales on the same day (May 21, 2026), including the CEO dispo | May 22, 2026 |
| KURA | CLUSTER | neutral | 2/10 | Three KURA C-suite insiders (COO, CLO, CCO) sold a total of $152K in open-market sales over a 7-day window, occurring 10 | May 22, 2026 |
| PHVS | CLUSTER | neutral | 3/10 | Five Pharvaris insiders, including the CEO and CCO, sold a total of ~$1.08M in open-market sales over a 7-day window, fo | May 22, 2026 |
| RPRX | CLUSTER | neutral | 2/10 | Two insiders at Royalty Pharma sold a combined $883K in open-market transactions over a one-week window. The sales repre | May 21, 2026 |
| NBIX | CLUSTER | neutral | 4/10 | Two directors sold $40.2M in NBIX shares ($2.36M and $37.82M) within days of Neurocrine's $2.9B acquisition of Soleno Th | May 21, 2026 |
| NKTR | CLUSTER | bearish | 5/10 | Two top executives at Nektar Therapeutics (CEO Howard Robin and Chief R&D Officer Jonathan Zalevsky) sold a combined $42 | May 21, 2026 |
| NBIX | CLUSTER | bearish | 5/10 | Two NBIX directors sold shares totaling ~$40.8M following the closing of the $2.9B Soleno acquisition, representing mode | May 21, 2026 |
| ZTS | CLUSTER | neutral | 2/10 | Two Zoetis directors made open-market purchases totaling $653K on May 13, 2026, a modest 0.002% of market cap. Director | May 21, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | Insider cluster at United Therapeutics shows CEO and CFO selling small amounts of stock after option exercises, total op | May 21, 2026 |
| ZLAB | CLUSTER | neutral | 3/10 | Two Zai Lab insiders (CEO and CLO) sold a combined $1.02M in open-market sales, less than 0.05% of market cap. These sal | May 21, 2026 |
| LEEEF | CLUSTER | bullish | 5/10 | CEO and CFO of Leef Brands made open-market purchases totaling ~$48K on May 18, 2026, with an additional non-cash compon | May 21, 2026 |
| MTEX | CLUSTER | mixed | 5/10 | Two directors at micro-cap Mannatech (MTEX) made open-market purchases totaling $62K over three trades in a 7-day window | May 21, 2026 |
| LQDA | CLUSTER | mixed | 5/10 | LQDA CEO Roger Jeffs sold $5.84M worth of stock over four consecutive trading days (May 15-20) at prices between $56.77 | May 20, 2026 |
| LQDA | CLUSTER | neutral | 4/10 | CEO Roger Jeffs and director Bloch Stephen sold a combined ~$11M in LQDA shares over the past week, representing 0.21% o | May 20, 2026 |
| HOWL | CLUSTER | neutral | 4/10 | Director Luke Evnin and 10% owner RA Capital Management sold a combined $72K in HOWL stock over a 7-day window, represen | May 20, 2026 |
| PHVS | CLUSTER | neutral | 3/10 | Four insiders at Pharvaris, including the CEO and Chief Commercial Officer, sold shares totaling $786K in open-market tr | May 20, 2026 |
| HUMA | CLUSTER | neutral | 3/10 | Two C-suite insiders (CFO and Chief Medical Officer) sold ~$82K in open-market sales on 2026-05-18, while a director bou | May 20, 2026 |